Skip to content
FORSIDEN
Log ind Opret konto
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Genmab
  4. Genmab — Januar 2026

Genmab — Januar 2026

Planlagt Fastgjort Låst Flyttet Genmab
295 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • E Offline
    E Offline
    E_L
    wrote on sidst redigeret af
    #253

    RAINFOL-05 (lung) starts recruiting https://clinicaltrials.gov/study/NCT07288177?tab=history&a=2&b=3#version-content-panel

    1 Reply Last reply
    0
    • E Offline
      E Offline
      E_L
      wrote on sidst redigeret af
      #254

      New trial sneaking in... : Study to Investigate Petosemtamab in Adults With Metastatic Non-Small Cell Lung Cancer https://clinicaltrials.gov/study/NCT07353957 even started recruiting already...

      1 Reply Last reply
      0
      • E Offline
        E Offline
        E_L
        wrote on sidst redigeret af
        #255

        i wonder if will get to see some early data from the Ph I / II solid tumors trial, on the NSCLC arm, Primary Completion was 2025-11 , but hasn't been updated for a long time https://clinicaltrials.gov/study/NCT03526835

        1 Reply Last reply
        0
        • E Offline
          E Offline
          E_L
          wrote on sidst redigeret af
          #256

          this could put the Acasunlimab decision in a different light (and even GEN1286)

          1 Reply Last reply
          0
          • P Offline
            P Offline
            peter12
            wrote on sidst redigeret af
            #257

            Spændende artikel om Peto https://www.irbbarcelona.org/en/news/scientific/mcla-158-first-clinical-candidate-screened-organoids-targeting-cancer-stem-cells

            1 Reply Last reply
            0
            • E Offline
              E Offline
              E_L
              wrote on sidst redigeret af
              #258

              small new trial City of Hope - Epcoritamab, Rituximab, Gemcitabine and Oxaliplatin (R-GemOx) as Salvage Therapy Before Autologous Stem Cell Transplant for the Treatment of Relapsed/​Refractory Diffuse Large B-Cell Lymphoma
              https://clinicaltrials.gov/study/NCT07365306

              1 Reply Last reply
              0
              • E Offline
                E Offline
                E_L
                wrote on sidst redigeret af
                #259

                small new trial - Testing the Effect of Teclistamab on Recurrent Plasmablastic Lymphoma https://clinicaltrials.gov/study/NCT07332507

                1 Reply Last reply
                0
                • B Offline
                  B Offline
                  bb8
                  wrote on sidst redigeret af
                  #260

                  https://endpoints.news/genmab-halts-enrollment-for-cancer-drug-from-profoundbio-buyout/ Genmab halts enrollment for cancer drug from ProfoundBio buyout

                  1 Reply Last reply
                  0
                  • P Offline
                    P Offline
                    ProinvestorNEWS
                    wrote on sidst redigeret af
                    #261

                    Go
                    dmorgen 🙂

                    1 Reply Last reply
                    0
                    • B Offline
                      B Offline
                      bibob
                      wrote on sidst redigeret af
                      #262

                      God morgen. 🙂

                      1 Reply Last reply
                      0
                      • J Offline
                        J Offline
                        JKY_VH
                        wrote on sidst redigeret af
                        #263

                        Har jeg misset nogle nyheder eller er den bare blevet for billig +1,75% på en studs

                        1 Reply Last reply
                        0
                        • T Offline
                          T Offline
                          transalp
                          wrote on sidst redigeret af
                          #264

                          Samme tanke her.. 🙂

                          1 Reply Last reply
                          0
                          • concilladoC Offline
                            concilladoC Offline
                            concillado
                            wrote on sidst redigeret af
                            #265

                            Hvornår har aktien ikke været for billig?? 😉

                            1 Reply Last reply
                            0
                            • concilladoC Offline
                              concilladoC Offline
                              concillado
                              wrote on sidst redigeret af
                              #266

                              Den ma da gerne falde, når der snart bliver udbetalt udbytte, som skal placeres 😄

                              1 Reply Last reply
                              0
                              • R Offline
                                R Offline
                                Raun
                                wrote on sidst redigeret af
                                #267

                                Det ligner en af de dage, hvor US af en eller anden grund handler aktien op

                                1 Reply Last reply
                                0
                                • nohopeN Offline
                                  nohopeN Offline
                                  nohope
                                  wrote on sidst redigeret af
                                  #268

                                  26/1 "Genmab halts enrollment for cancer drug from ProfoundBio buyout" Ingen der har kommentarer til dette ?

                                  1 Reply Last reply
                                  0
                                  • R Offline
                                    R Offline
                                    Raun
                                    wrote on sidst redigeret af
                                    #269

                                    Er det ikke samme emne @bb8 havde i aftes?

                                    1 Reply Last reply
                                    0
                                    • G Offline
                                      G Offline
                                      gentogen
                                      wrote on sidst redigeret af
                                      #270

                                      Det må vist betegnes som forventet. Meget lille studie på 4 klinikker og på ingen måde en vigtig del af baggrunden for købet.

                                      1 Reply Last reply
                                      0
                                      • G Offline
                                        G Offline
                                        gentogen
                                        wrote on sidst redigeret af
                                        #271

                                        Kan såmænd lige så godt være et positivt tegn på, at de har noget andet og bedre inden for samme område, hvis man endelig vil lægge noget i det ...

                                        1 Reply Last reply
                                        0
                                        • E Offline
                                          E Offline
                                          E_L
                                          wrote on sidst redigeret af
                                          #272

                                          The news is 2 weeks old. We’ll hear at some point what the exact reason is, but my guess is that they will go with ‘portfolio prioritisation’ 😉

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper